NCT05512676View on ClinicalTrials.gov

Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

March 7, 2016

Primary Completion Date

May 20, 2019

Study Completion Date

August 1, 2022

Conditions
Ovarian NeoplasmChemotherapeutic ToxicityChemotherapy EffectChemotherapy-induced NeutropeniaChemotherapy-induced Nausea and Vomiting
Sponsors

Collaborators (1)

Swedish Orphan Biovitrum
All Listed Sponsors
collaborator

Swedish Orphan Biovitrum

INDUSTRY

lead

Oslo University Hospital

OTHER